Timolol for the Prevention of Proliferation of Infantile Hemangioma (TiPPIH Trial)

Clinical trial NCT01434849 · TERMINATED

Trial details

NCT number: NCT01434849
Sponsor: Alice K. Gong
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Infantile Hemangioma Very Low Birth Weight Infants

Start date: 2012-07-01
Primary completion: 2016-04-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.